1Weiss LM,Wamke RA,Sklar J,et al.Molecular analysis of the t( 14; 18 ) chromosomal translocation in malignant lymphomas[ J ].New England Journal of Medicine,1987,317:1185 - 1189.
2Finbarr E,Cotter.The Role of The bcl-2 Gene In Lymphoma[ J].British Journal of Haematology,1990,75:449 - 453.
3James AL,Fenton,Jan-Willem Vaandrager,et al.Follicular Lymphoma with a novel t( 14; 18 ) breakpoint involving the immunogobulin heavy chain switch mu region indicates an origin from germinal center B cells [ J ].Blood,2002,99 ( 2 ): 716 -718.
4Macintyre EA,Delabesse E.Molecular Approaches to the Diagnosis and Evaluation of Lymphoid Malignancies[ J].Seminars in Hematology ,1999,36,(4) :373 - 389.
6Sara Galimberti,Francesca Brizzi,Marina Mameli,et al.An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease detection [ J ].Leukemia Research,1999,23:921 -929.
8Olsson K,Gerard CJ,ZehnderJ,etal.Real-timet(11;14)and t( 14; 18 ) PCR assays provide sensitive and quantitative assessments of minimal residual disease(MRD) [ J ].Leukemia,1999,13( 11 ): 1833 - 1842.
9Apostolids J,Gupta PK,Grenzelias D,et al.High-does therapy with autologous bone marrowsuppport as consolidation of remission in follicular lymphoma:long-term clinical and molecular follow-up[ J].J Clin Oncol,2000,18 :527 - 536.
10Mitterbauer M,Neumeister,P,Kalhs,P,et al.Long-term clinical and molecular remission after allogeneic stem cell transplantation(SCT) in patients with poor prognosis non-Hodgkin' s lymphoma [ J ].Leukemia,2001,15 (4) :635 - 641.
二级参考文献16
1Shipp MA, Abeloff MD, Antman KH, et al. International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin′s lymphomas: report of the jury. J Clin Oncol, 1999, 17:423-429.
2Zwicky CS, Maddocks AB, Anderson N, et al. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin′s lymphoma is associated with decreased relapse after autologous bone marrow transplantation. Blood, 1996, 88:3314-3322.
3Leonard B, Hetu F, Busque L, et al. Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources. Blood, 1998, 91:331-339.
4Signoretto S, Murphy M, Cangi MG, et al. Detection of clonal T-cell receptor γ Gene rearramgements in paraffin-embeded tissue by polymerase chain reaction and nonradioactive single-strand conformational polymorphism analysis. Am J Pathol, 1999,154:62-76.
5Baruchel A, Cayuela JM, MacIntyre E, et al. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods:implication for a general strategy of minimal residual disease detection. Br J Haematol, 1995, 90:85-93.
6Pappa VI, Wilkes S, Salam A, et al. Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma before and after in vitro treatment. Bone Marrow Transplant, 1998, 22:553-558.
7Jacquy C, Lambert F, Soree A, et al. Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging? Bone Marrow Transplant, 1999, 23:681-686.
8Kanteti R, Miller K, McCann JC, et al. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin′s lymphoma and Hodgkin′s disease: a clinical and molecular analysis. Bone Marrow Transplant, 1999, 24:473-481.
9Blystad AK, Kvalheim G, Torlakovic E, et al. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin′s lymphoma. Bone Marrow Transplant, 1999, 24:865-872.
10Jacquy C, Soree A, Lambert F, et al. A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin′s lymphoma: one-half of patients significantly mobilize malignant cells. Br J Haematol, 2000, 110:631-637.
